Symbol
LXEO on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership
2.77M shares
Security Ownership
3.8%

Longitude Capital Partners IV, LLC ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)

2025-11-14 - Longitude Capital Partners IV, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.77M shares of Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO). This represents 3.8% percent ownership of the company.